UCLA’s Dr. Michael Gandal said that beyond the important new findings, he is even more optimistic about what the data will help researchers learn in the future.
A UCLA-led analysis identifies brain measures of major psychiatric disease. Researchers also pinpointed important differences in these disorders’ gene expression.
The grant “will allow UCLA to continue our decade-long preeminence in groundbreaking autism research,” said Dr. Daniel Geschwind, director of the UCLA Center for Autism Research and Treatment.
After 10 weeks, children who had received a UCLA-developed intervention for autism were spending more time interacting with others rather than playing independently.
UCLA researchers have identified a signature brain-wave pattern for children with autism spectrum disorder related to a genetic condition. They say this signature is among the first quantitative biomarkers for any syndrome associated with autism spectrum disorder.
UCLA’s Dr. Daniel Geschwind said the findings could point the way to the development of drugs that reverse the specific type of gene activity patterns in the brains of people with the disorder.